flurbiprofen has been researched along with am 251 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ates, M; Gühring, H; Hamza, M; Seidel, K | 1 |
| Ates, M; Gühring, H; Hamza, M; Kotalla, CE; Ledent, C; Seidel, K | 1 |
2 other study(ies) available for flurbiprofen and am 251
| Article | Year |
|---|---|
Flurbiprofen inhibits capsaicin induced calcitonin gene related peptide release from rat spinal cord via an endocannabinoid dependent mechanism.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Calcitonin Gene-Related Peptide; Cannabinoid Receptor Modulators; Capsaicin; Cyclooxygenase Inhibitors; Dinoprostone; Dronabinol; Endocannabinoids; Fatty Acids, Unsaturated; Flurbiprofen; Immunoassay; In Vitro Techniques; Phospholipases A; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Spinal Cord | 2003 |
Intrathecally applied flurbiprofen produces an endocannabinoid-dependent antinociception in the rat formalin test.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cannabinoid Receptor Modulators; Cyclooxygenase Inhibitors; Dinoprostone; Endocannabinoids; Enzyme Inhibitors; Flurbiprofen; Formaldehyde; In Vitro Techniques; Injections, Spinal; Male; Mice; Muscle Contraction; Muscle, Smooth; Pain Measurement; Phospholipases A; Phospholipases A2; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Vas Deferens | 2003 |